JavaScript is disabled for your browser. Some features of this site may not work without it.
Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
Hypertensive disorders in pregnancy : 2019 national guideline
Moodley, J.; Soma-Pillay, Priya; Buchmann, E.; Pattinson, Robert Clive
BACKGROUND: Hypertensive disorders of pregnancy (HDP), including pre-eclampsia/eclampsia, account for significant maternal and fetal
mortality globally and especially in South Africa.
OBJECTIVE: To formulate clinical guidelines for the management of HDP in order to substantially reduce the number of maternal deaths
from HDP.
METHODS: The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was used to formulate the guidelines and
included six domains: scope and purpose; stakeholder involvement; rigour and development; clarity of presentation; applicability; and
editorial independence.
RECOMMENDATIONS: The guideline stipulates management strategies for all levels of care where women with hypertensive disorders in
pregnancy are seen. It also has a detailed implementation plan.
CONCLUSION: A clinical guideline that is of practical value has been formulated by a wide group of stakeholders. It is hoped that its
dissemination and implementation by all doctors and nurses will reduce mortality and morbidity associated with HDP.